Biological targeting agents
AssigneeAmersham International plc
InventorsGary Robert Bower, Alan Michael Forster, Anthony Leonard Mark Riley, Anthony Eamon Storey
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmersham International plc
InventorsGary Robert Bower, Alan Michael Forster, Anthony Leonard Mark Riley, Anthony Eamon Storey
Estimating the term…
A conjugate comprises a linear or cyclic synthetic peptide of 3-50 amino acids linked via one of its carboxyl groups and optionally via a linking group, to a polydentate metal chelating group, with the result that endo- or exo-peptidase metabolism of the peptide is substantially inhibited, with the provisos that: a) the peptide chain contains a biological targeting sequence which is biologically active; b) when the spacer is absent the metal chelating group does not comprise solely peptide moieties; c) the metal chelating group does not contain thiol donors. A complex of the conjugate with a metal atom chelated by the metal chelating group is useful in medicine.
A conjugate comprising a linear or cyclic synthetic peptide of 3-50 amino acids linked via one of its carboxyl groups and optionally via a linking group, to a polydentate metal chelating group, with the result that endo- or exo-peptidase metabolism of the peptide is substantially inhibited, with the provisos that:
Dependencies are inferred from the claim text.